MIR6768

Across TCGA pan-cancer cohorts, MIR6768 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of MIR6768’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where MIR6768 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR6768 is over-expressed in tumor.

LUAD, LUSC, and COAD are the cancer types where MIR6768 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR6768 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.171	.004	6	view →
LUSC	Male	All	+0.322	<.001	4	view →
COAD	All	II,III,IV	+0.304	.007	4	view →
BRCA	All	II,III,IV	+0.246	<.001	4	view →
HNSC	All	All	+0.158	.018	3	view →
UCEC	All	All	+0.437	.014	2	view →
BLCA	All	All	+0.258	.038	2	view →
LIHC	All	All	+0.150	.007	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

MIR6768–LUAD

Open the LUAD breakdown →